Skip to primary navigation
Skip to main content
Skip to footer

Kalaris Therapeutics

Your vision, our mission

About Us
Our Science
Leadership Team
Contact
Investors & Press

Home/Uncategorized/AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina

AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina

November 7, 2024

Footer

© Kalaris Therapeutics 2025. All rights reserved.

About Us
Our Science
Leadership Team
Contact
Investors & Press